Real-world treatment patterns and clinical outcomes in Korean patients with AML ineligible for first-line intensive chemotherapy: A subanalysis of the CURRENT study, a non-interventional, retrospective chart review
Soo-Mee Bang, Ka-Won Kang, Ik-Chan Song, Alexander Delgado, Cynthia Llamas, Yinghui Duan, Ji-Young Jeong, Je-Hwan Lee
doi: https://doi.org/10.1101/2022.06.15.22276442
Soo-Mee Bang
1Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University, College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea
Ka-Won Kang
2Division of Hematology and Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea
Ik-Chan Song
3Division of Hematology and Oncology, Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea
Alexander Delgado
4Medical Affairs, Oncology JAPAC, AbbVie Singapore Pte Ltd, Singapore
Cynthia Llamas
5Evidence Solutions, AbbVie Inc., North Chicago, IL, USA
Yinghui Duan
5Evidence Solutions, AbbVie Inc., North Chicago, IL, USA
Ji-Young Jeong
6Medical Affairs, AbbVie Korea Ltd, Seoul, Korea
Je-Hwan Lee
7Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Article usage
Posted June 20, 2022.
Real-world treatment patterns and clinical outcomes in Korean patients with AML ineligible for first-line intensive chemotherapy: A subanalysis of the CURRENT study, a non-interventional, retrospective chart review
Soo-Mee Bang, Ka-Won Kang, Ik-Chan Song, Alexander Delgado, Cynthia Llamas, Yinghui Duan, Ji-Young Jeong, Je-Hwan Lee
medRxiv 2022.06.15.22276442; doi: https://doi.org/10.1101/2022.06.15.22276442
Real-world treatment patterns and clinical outcomes in Korean patients with AML ineligible for first-line intensive chemotherapy: A subanalysis of the CURRENT study, a non-interventional, retrospective chart review
Soo-Mee Bang, Ka-Won Kang, Ik-Chan Song, Alexander Delgado, Cynthia Llamas, Yinghui Duan, Ji-Young Jeong, Je-Hwan Lee
medRxiv 2022.06.15.22276442; doi: https://doi.org/10.1101/2022.06.15.22276442
Subject Area
Subject Areas
- Addiction Medicine (394)
- Allergy and Immunology (706)
- Anesthesia (197)
- Cardiovascular Medicine (2885)
- Dermatology (247)
- Emergency Medicine (433)
- Epidemiology (12626)
- Forensic Medicine (10)
- Gastroenterology (814)
- Genetic and Genomic Medicine (4487)
- Geriatric Medicine (410)
- Health Economics (717)
- Health Informatics (2870)
- Health Policy (1059)
- Hematology (379)
- HIV/AIDS (912)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4254)
- Nursing (228)
- Nutrition (622)
- Oncology (2229)
- Ophthalmology (635)
- Orthopedics (255)
- Otolaryngology (323)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (491)
- Pediatrics (1183)
- Primary Care Research (489)
- Public and Global Health (6834)
- Radiology and Imaging (1504)
- Respiratory Medicine (910)
- Rheumatology (431)
- Sports Medicine (376)
- Surgery (476)
- Toxicology (60)
- Transplantation (206)
- Urology (176)